GlassScriptMammomat Revelation
Payments companies reported to CMS as associated with Mammomat Revelation. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mammomat Revelation, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mammomat Revelation
These are the largest totals companies reported as associated with Mammomat Revelation. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jason Shames | Philadelphia, PA | Diagnostic Radiology | $11,482.09 |
| Tanya Moseley | Houston, TX | Diagnostic Radiology | $10,060.46 |
| Shadi Aminololama Shakeri | Sacramento, CA | $9,137.32 | |
| Noel Bergquist | Knoxville, TN | Diagnostic Radiology | $4,184.76 |
| Ashlee Byrd | Philadelphia, PA | Diagnostic Radiology | $2,482.82 |
| Alice Rim | Cleveland, OH | Diagnostic Radiology | $1,938.43 |
| Laura Shepardson | Cleveland, OH | Diagnostic Radiology | $1,938.43 |
| Peter Liu | Cleveland, OH | Diagnostic Radiology | $1,824.25 |
| Daniel Lockwood | Cleveland, OH | Diagnostic Radiology | $1,679.07 |
| Janet Szabo | New York, NY | Diagnostic Radiology | $1,216.67 |
Prescribed Mammomat Revelation?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.